2nd Annual Forum on Anonymous-Patient Level Data & Analysis

Featured Conference 2nd Annual Forum on Anonymous-Patient Level Data & Analysis June 3-4, 2004 ...

The Indian Pharmaceutical Market

The Indian pharmaceutical market is the world's fourth largest by volume (8% of global total) and thirteenth largest by value (less than 1% of global total).

Pharma eMarketing: A Level Playing Field or a Killing Field?

Why is pharma so conservative when it comes to using technology for marketing purposes? Is it ROI concerns? Not invented here syndrome? Or is it something else?

Are ED Ads Too Sexually Explicit?

The TV DTC ad campaigns for Cialis, Levitra, and Viagra seem to be pushing the envelope with regard to sexually-explicit themes and characters. Recently, we asked Pharma Marketing News readers and Pharma Marketing Network Web site visitors to give us their opinions about whether or not recent ED TV ads were too sexually explicit or focusing on a younger and younger audience.

The New Branding Model: From Blockbusters to Targeted Therapies

Targeted therapies, based upon genotype, require a new brand model that addresses smaller segments of the population. This model, according to Francoise Simon, professor of marketing at the Columbia University Graduate School of Business, requires a fundamental reorganization of the biopharma value chain, from discovery to manufacturing and marketing.

eDetailing Strategies for a Higher Physician Response

Most pharmaceutical firms have piloted eDetailing programs and scaled them successfully. However, although Traditional eDetailing has been around for at least 5 years, marketers must expand the definition of eDetailing. To this end Croom offers a Best Practice Guide for eDetailing to help pharma marketers optimize the reach and impact of eDetailing.

ePrescribing: What Role Should Pharma Play?

A panel entitled What Role Should Pharma Play in ePrescribing and the Point-of-Care? at a recent ePharma Summit conference held in Philadelphia, PA, discussed the issues facing pharmaceutical companies as electronic prescribing (ePrescribing or eRx) threatens to upset the "balance of power" between physicians, pharma companies, and payers at the point-of-care.

Ready or Not: Gearing Up for the Expansion of ePrescribing

In a keynote address at a recent ePharma Summit conference held in Philadelphia, PA, Kevin Hutchinson, CEO and President of SureScripts, a company founded by the National Association of Chain Drug Stores (NACDS) and the National Community Pharmacists Association, looked at the changing landscape and inevitability of electronic prescribing (ePrescribing or eRx) and the implications and opportunities for the pharmaceutical industry.

Pharma Marketing News Vol. 3, #6 (June 2004) Archive

Dear Reader, Welcome to the archive of the June, 2004 issue of Pharma Marketing News! Vol....

Publication Planning 2004

Featured Conference Publication Planning 2004 Practical Strategies for Publication Planning May 24-27, 2004 • Princeton, NJ ...